Fig. 2

Kaplan–Meier curves of OS after administration of cabazitaxel according to the automated bone scan index (aBSI). The blue line indicates survival of patients with aBSI < 1% (n = 17), and the green line indicates survival of patients with aBSI ≥1% (n = 31). The median OS of patients with aBSI < 1% and aBSI ≥1% was not reached and 7.8 months (95%CI, 4.6–10.9), respectively (p = 0.027)